Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombosis and immune disorders.

J Vermylen, D Blockmans, B Spitz

    Clinics in Haematology
    |May 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Clinicians should consider immune system disorders in patients with thrombosis. Investigating immune disturbances like complement abnormalities or antibodies may reveal underlying causes of blood clot formation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cough as a clinical manifestation of giant cell arteritis.

    Scandinavian journal of rheumatology·2026
    Same author

    Flemish network on rare connective tissue diseases (CTD): patient pathways in systemic sclerosis. First steps taken.

    Acta clinica Belgica·2023
    Same author

    Association between diagnostic outcomes and symptom pattern in fever and inflammation of unknown origin.

    European journal of internal medicine·2023
    Same author

    Etiological spectrum and outcome of fever and inflammation of unknown origin. Does symptom duration matter?

    European journal of internal medicine·2022
    Same author

    Rheumatic disorders among patients with fever of unknown origin: A systematic review and meta-analysis.

    Seminars in arthritis and rheumatism·2022
    Same author

    Diagnosis of deficiency of adenosine deaminase type 2 in adulthood.

    Scandinavian journal of rheumatology·2021
    Same journal

    Myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.

    Clinics in haematology·1986
    Same journal

    Myelodysplastic syndromes: natural history and features of prognostic importance.

    Clinics in haematology·1986
    Same journal

    Pathogenesis and clinical variations in the myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    The treatment of myelodysplastic syndromes.

    Clinics in haematology·1986
    Same journal

    Secondary myelodysplastic syndromes and leukaemias.

    Clinics in haematology·1986
    See all related articles

    Area of Science:

    • Immunology
    • Hematology
    • Vascular Biology

    Background:

    • Thrombosis is a significant clinical concern.
    • The role of immune system disturbances in thrombosis is increasingly recognized.
    • Existing research highlights connections between immune disorders and thrombotic events.

    Purpose of the Study:

    • To alert clinicians to the potential link between thrombosis and immune system abnormalities.
    • To review various immune mechanisms that may contribute to thrombogenesis.
    • To encourage further research into the immunological aspects of blood clot formation.

    Main Methods:

    • Literature review of clinical cases and immunological studies.
    • Analysis of associations between specific immune disorders and thrombosis.

    Related Experiment Videos

  • Discussion of proposed pathophysiological mechanisms.

    • Main Results:

    • Immune disturbances identified as potential causes of thrombosis include complement system abnormalities (e.g., acquired angioneurotic edema, paroxysmal nocturnal hemoglobinuria).
    • Cell-mediated immunological damage to the vessel wall (e.g., Behcet's syndrome, Buerger's disease) is implicated.
    • Circulating antibodies, such as lupus anticoagulant and anti-heparin antibodies, are associated with thrombotic risk.

    Conclusions:

    • Awareness of the association between thrombosis and immune disorders is crucial for clinical practice.
    • Further detailed studies are needed to elucidate the mechanisms linking immune system dysfunction and thrombogenesis.
    • Enhanced understanding of immune roles in thrombogenesis will improve patient management and treatment strategies.